Slabý O - Search Results

1

Role of miR-653 and miR-29c in downregulation of CYP1A2 expression in hepatocellular carcinoma.

Krkoška M, Nekvindová J, Nevědělová K, Zubáňová V, Radová L, Vondráček J, Herůdková J, Slabý O, Kiss I, Bohovicová L, Fabian P, Tylichová Z, Kala Z, Kysela P, Ostřížková L, Palička V, Hyršlová Vaculová A. Krkoška M, et al. Among authors: slaby o. Pharmacol Rep. 2022 Feb;74(1):148-158. doi: 10.1007/s43440-021-00338-9. Epub 2021 Nov 15. Pharmacol Rep. 2022. PMID: 34780054

2

Altered expression of miR-21, miR-31, miR-143 and miR-145 is related to clinicopathologic features of colorectal cancer.

Slaby O, Svoboda M, Fabian P, Smerdova T, Knoflickova D, Bednarikova M, Nenutil R, Vyzula R. Slaby O, et al. Oncology. 2007;72(5-6):397-402. doi: 10.1159/000113489. Epub 2008 Jan 15. Oncology. 2007. PMID: 18196926 Clinical Trial.

3

Significant overexpression of Hsp110 gene during colorectal cancer progression.

Slaby O, Sobkova K, Svoboda M, Garajova I, Fabian P, Hrstka R, Nenutil R, Sachlova M, Kocakova I, Michalek J, Smerdova T, Knoflickova D, Vyzula R. Slaby O, et al. Oncol Rep. 2009 May;21(5):1235-41. doi: 10.3892/or_00000346. Oncol Rep. 2009. PMID: 19360299

4

Gene expression of somatostatin receptor 4 predicts clinical outcome of patients with metastatic neuroendocrine tumors treated with somatostatin analogs.

Slaby O, Sachlova M, Bednarikova M, Fabian P, Svoboda M, Vytopilova S, Valik D, Vyzula R. Slaby O, et al. Cancer Biother Radiopharm. 2010 Apr;25(2):237-43. doi: 10.1089/cbr.2009.0708. Cancer Biother Radiopharm. 2010. PMID: 20423238

5

Expression of miRNA-106b in conventional renal cell carcinoma is a potential marker for prediction of early metastasis after nephrectomy.

Slaby O, Jancovicova J, Lakomy R, Svoboda M, Poprach A, Fabian P, Kren L, Michalek J, Vyzula R. Slaby O, et al. J Exp Clin Cancer Res. 2010 Jul 7;29(1):90. doi: 10.1186/1756-9966-29-90. J Exp Clin Cancer Res. 2010. PMID: 20609231 Free PMC article.

6

MicroRNAs and their target gene networks in renal cell carcinoma.

Redova M, Svoboda M, Slaby O. Redova M, et al. Among authors: slaby o. Biochem Biophys Res Commun. 2011 Feb 11;405(2):153-6. doi: 10.1016/j.bbrc.2011.01.019. Epub 2011 Jan 11. Biochem Biophys Res Commun. 2011. PMID: 21232526 Review.

7

MicroRNAs and glioblastoma: roles in core signalling pathways and potential clinical implications.

Sana J, Hajduch M, Michalek J, Vyzula R, Slaby O. Sana J, et al. Among authors: slaby o. J Cell Mol Med. 2011 Aug;15(8):1636-44. doi: 10.1111/j.1582-4934.2011.01317.x. J Cell Mol Med. 2011. PMID: 21435175 Free PMC article. Review.

8

Multifunctional immune-modulatory protein HLA-E identified in classical Hodgkin lymphoma: possible implications.

Kren L, Fabian P, Slaby O, Janikova A, Soucek O, Sterba J, Krenova Z, Michalek J, Kral Z. Kren L, et al. Among authors: slaby o. Pathol Res Pract. 2012 Jan 15;208(1):45-9. doi: 10.1016/j.prp.2011.11.004. Epub 2011 Dec 15. Pathol Res Pract. 2012. PMID: 22177730

9

Expression levels of transcribed ultraconserved regions uc.73 and uc.388 are altered in colorectal cancer.

Sana J, Hankeova S, Svoboda M, Kiss I, Vyzula R, Slaby O. Sana J, et al. Among authors: slaby o. Oncology. 2012;82(2):114-8. doi: 10.1159/000336479. Epub 2012 Feb 11. Oncology. 2012. PMID: 22328099

10

MiR-34b is associated with clinical outcome in triple-negative breast cancer patients.

Svoboda M, Sana J, Redova M, Navratil J, Palacova M, Fabian P, Slaby O, Vyzula R. Svoboda M, et al. Among authors: slaby o. Diagn Pathol. 2012 Mar 22;7:31. doi: 10.1186/1746-1596-7-31. Diagn Pathol. 2012. PMID: 22439831 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

349 results

Search Page